"Given these market conditions, provider competition could, alternatively, result in higher use rates and costs".
Multi-provider competition would be a boon for the U.S. consumer.
Centers will also need to focus on delivering an excellent patient experience; having shorter wait times and extended hours will be important in a world of increased provider competition (and it will also be good for patients!).
Regulations intended to maximise provider diversity and competition for patients thus remove provider competition as a medium of power for the commissioners.
In particular, patient choice of provider inhibits commissioners' use of provider competition as a means of control.
These are: negotiated order, provider competition, financial incentives, ideological and disciplinary control, juridical governance and managerial performance.
In surrogate planning, a different kind of negotiated order, provider competition and financial incentives and penalties dominate.
A reduction in the number of CABG and PCI providers may also result in higher prices for health care purchasers as provider competition is reduced.
This article evaluates one recent set of market-based health reforms introduced in the English National Health Service (NHS) from 2002 to 2008, which focused on introducing patient choice and provider competition.
To enable provider competition, products were defined in terms of Diagnosis Treatment Combinations (DTCs), which are to some extent comparable to diagnosis related groups [ 11].
